Governor Edmund G. Brown Jr. announced 17 appointments Nov. 20, including Dr. Jason Bush, associate professor of cancer biology at Fresno State, who will serve a four-year term on the Carcinogen Identification Committee (CIC).
As a result of Proposition 65, the scientific committee was formed to determine which chemicals in California are classified as carcinogens, or cancer-causing agents.
“I am delighted to serve on the CIC,” said Bush. “The tasks of the committee are important for the health and welfare of Californians and I am especially hopeful to be a productive advocate for the unique health and environmental issues facing the Central Valley.”
Bush has a broad background in cancer biology, biological research on cancer cell models and animal models and applications proteomic technologies to data discovery. He is the primary investigator on several university and National Institute of Health funded grants, which have laid the groundwork for incorporating ethnic minorities and underserved populations into research that addresses critical health-disparities common to Central California.
He also administered the creation of the RIMI Functional Genomics and Proteomics Facility at Fresno State, where students and faculty engage in cutting-edge cancer biology research. “The Effects of Central Valley Pesticides on Breast Epithelial Cells in Hispanic/Latina Farmworkers” and “Marital Caregiving Interactions in Alzheimer’s Disease,” are two independent projects currently being supported by the program and its students.
Bush earned his Ph.D. in experimental medicine/cancer biology from the University of British Columbia in Vancouver, with a focus on the chemoresistance mechanisms of melanoma and other skin cancers. He pursued post-doctoral training at the Sanford-Burnham Medical Research Institute, where he served as a post-doctoral fellow 2002-2006, with focus on molecular profiling of breast cancer. Since 2006, he has been at Fresno State researching work with cell models and a range of biological problems addressing breast, ovarian and pancreatic cancer.
For more information, contact Dr. Bush at 559.278.2068.
(Copy prepared by University Communications news student assistant Alejandra Garcia.)